CPRX News and Press, Catalyst Pharmaceuticals Inc. From 08/19/20

Are You Looking For Top Biotech Stocks To Buy? If Yes, Are These 2 On Your List? Biotech stocks have emerged as a popular asset class to watch this year. More specifically, small-cap biotech stocks are making big moves like never before. For this reason, it is gathering a lot of investor a...

Robinhood investors apparently like pharmaceutical stocks , but a quick perusal of some of their favorites bring up three awful choices and one that might just turn out to be a good one. Buying stocks that are popular with a certain group of investors isn't inherently a bad idea, but it makes ...

Catalyst Pharmaceuticals (NASDAQ: CPRX ) enters into an agreement with Mississauga, Ontario-based KYE Pharmaceuticals under which the latter will commercialize Firdapse (amifampridine phosphate) in Canada for the treatment of adults with an autoimmune disorder called Lambert-Eaton myast...

CORAL GABLES, Fla., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurologic...

Are These Robinhood Penny Stocks On Your Watch List Right Now? Penny stocks are one of the main attractions for new traders this year. One of the fastest-growing platforms thanks to its “game-like” set-up has been Robinhood. Penny stocks on this platform are easily accessible t...

Robinhood, a free app offering commission-free trading of stocks, options, and more, has attracted a lot of attention in recent months. Many investors who use it seem drawn to specific names, and they're not necessarily stocks that receive a lot of coverage. Among Robinhood's 100 most popular s...

Image source: The Motley Fool. Catalyst Pharmaceuticals Inc   (NASDAQ: CPRX) Q2 2020 Earnings Call Aug 11, 2020 , 8:30 a.m. ET Operator Continue reading

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2020 Earnings Conference Call August 11, 2020 08:30 AM ET Company Participants Alicia Grande - Chief Financial Officer Patrick McEnany - Chairman and Chief Executive Officer Jeffrey Del Carmen - Chief Commercial Officer Steven Miller - C...

Shares of the rare-disease drugmaker Catalyst Pharmaceuticals (NASDAQ: CPRX) are under pressure Tuesday morning. Specifically, the biopharma's shares dropped by as much as 12.5% in pre-market trading today. Catalyst's stock is sinking in response to the news that the company's effort to exp...

Fennec Pharmaceuticals (NASDAQ: FENC )   -31%  on FDA rejection of Pedmark application. More news on: Fennec Pharmaceuticals Inc., Mesoblast Limited, Genesis Healthcare, Inc., Stocks on the move, , Read more ...